Vall D’Hebron Institute Of Research (Vhir) - Vall D'Hebron Institut De Recerca

Vall D’Hebron Institute Of Research (Vhir) - Vall D'Hebron Institut De Recerca company information, Employees & Contact Information

We are a public sector institution that promotes and develops the biomedical research, innovation and teaching at Vall d'Hebron University Hospital, the hospital of Barcelona and the largest of Catalan Institute of Health (ICS). The members of our Board of Trustees are the Catalan Ministry of Health, the Catalan Ministry of Economy and Knowledge (we are a CERCA center), Vall d'Hebron University Hospital, Bank of blood and tissues, the Autonomous University of Barcelona (UAB), of which we are an accredited research institute, and the Vall d'Hebron Institute of Oncology (VHIO), which together with VHIR is part of Accredited Institute of Campus Vall d’Hebron Institute by the Institute of Health Carlos III (ISCIII). Since its creation in 1994, VHIR works to find solutions to the health problems of society, and contribute to spread them around the world. In more than 20 years we have achieved leadership in biomedical research at hospitals in our country, and we want to be recognised in 2020 as an excellent and competitive European Institute leader in clinical and traslational research linked to a university hospital. In our institute are working more than 1,300 people, of which over 1,200 doing research and others, around 100, help to do it or transfer it to the society once made, whether in the form of projects, technology transfer and innovation, communication or fundraising, among others. The best of our institution and its research staff is doing research to solve people’s health problems. Our task is not only basic or translational, we are leaders in clinical research. We have the beds of the hospital separated in less than 50 meters of laboratories and our patients will benefit from our research. In this we believe, and our efforts are focused on it. This is understood by industry leaders who are committed to our hospital, making it a world reference for its first clinical trials.

Company Details

Employees
972
Founded
-
Address
Pg. Vall D'hebron, 119-129, Barcelona,barcelona 08035,spain
Industry
Research Services
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Website
vhir.org
HQ
Barcelona, Barcelona
Looking for a particular Vall D’Hebron Institute Of Research (Vhir) - Vall D'Hebron Institut De Recerca employee's phone or email?

Vall D’hebron Institute Of Research (Vhir) - Vall D'hebron Institut De Recerca Questions

News

A hundred professionals participate in the VHIR Faculty Retreat - Vall d'Hebron Barcelona Hospital Campus

A hundred professionals participate in the VHIR Faculty Retreat Vall d'Hebron Barcelona Hospital Campus

An urban fold. VHIR Research Center, Vall d'Hebron Campus, by BAAS + ESPINET/UBACH - Metalocus

An urban fold. VHIR Research Center, Vall d'Hebron Campus, by BAAS + ESPINET/UBACH Metalocus

Vall d'Hebron Research Institute (VHIR) inaugurates new building - uab.cat

Vall d'Hebron Research Institute (VHIR) inaugurates new building uab.cat

VHIR implements a new innovation model to maximize the impact of health research - Vall d'Hebron Barcelona Hospital Campus

VHIR implements a new innovation model to maximize the impact of health research Vall d'Hebron Barcelona Hospital Campus

Molecular signature associated with cladribine treatment in patients with multiple sclerosis - Frontiers

Molecular signature associated with cladribine treatment in patients with multiple sclerosis Frontiers

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS - Neurology® Journals

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS Neurology® Journals

Clinical efficacy of a virtual reality tool for the treatment of obesity: study protocol of a randomised controlled trial - BMJ Open

Clinical efficacy of a virtual reality tool for the treatment of obesity: study protocol of a randomised controlled trial BMJ Open

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction - JACC Journals

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction JACC Journals

The Vall d'Hebron Research Institute (VHIR) has received - Vall d'Hebron Barcelona Hospital Campus

The Vall d'Hebron Research Institute (VHIR) has received Vall d'Hebron Barcelona Hospital Campus

Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance? - Frontiers

Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance? Frontiers

Editorial: Human Intestinal Permeability, Mucosal Inflammation and Diet - Frontiers

Editorial: Human Intestinal Permeability, Mucosal Inflammation and Diet Frontiers

Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste - Frontiers

Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste Frontiers

FDA grants orphan drug designation to a gene therapy for ALS developed in collaboration with VHIR - Vall d'Hebron Barcelona Hospital Campus

FDA grants orphan drug designation to a gene therapy for ALS developed in collaboration with VHIR Vall d'Hebron Barcelona Hospital Campus

Editorial: Sphingolipid metabolism and cancer - Frontiers

Editorial: Sphingolipid metabolism and cancer Frontiers

Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control study - Frontiers

Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control study Frontiers

MiRNA-based therapeutic potential in multiple sclerosis - Frontiers

MiRNA-based therapeutic potential in multiple sclerosis Frontiers

Functional Recovery and Serum Angiogenin Changes According to Intensity of Rehabilitation Therapy After Stroke - Frontiers

Functional Recovery and Serum Angiogenin Changes According to Intensity of Rehabilitation Therapy After Stroke Frontiers

Assessment of dyspneic sensation in patients with type 2 diabetes - Frontiers

Assessment of dyspneic sensation in patients with type 2 diabetes Frontiers

New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes - Frontiers

New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes Frontiers

Novel variant in HHAT as a cause of different sex development with partial gonadal dysgenesis associated with microcephaly, eye defects, and distal phalangeal hypoplasia of both thumbs: Case report - Frontiers

Novel variant in HHAT as a cause of different sex development with partial gonadal dysgenesis associated with microcephaly, eye defects, and distal phalangeal hypoplasia of both thumbs: Case report Frontiers

VHIR receives a Joan Roget Award for Knowledge Transfer | - Vall d'Hebron Barcelona Hospital Campus

VHIR receives a Joan Roget Award for Knowledge Transfer | Vall d'Hebron Barcelona Hospital Campus

Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy - Baishideng Publishing Group

Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy Baishideng Publishing Group

VHIR coordinates TRUSTroke, a European artificial intelligence project aimed at optimising stroke treatment - Vall d'Hebron Barcelona Hospital Campus

VHIR coordinates TRUSTroke, a European artificial intelligence project aimed at optimising stroke treatment Vall d'Hebron Barcelona Hospital Campus

Identification and Characterization of New RNASEH1 Mutations Associated With PEO Syndrome and Multiple Mitochondrial DNA Deletions - Frontiers

Identification and Characterization of New RNASEH1 Mutations Associated With PEO Syndrome and Multiple Mitochondrial DNA Deletions Frontiers

Antigen-Dependent T Cell Response to Neural Peptides After Human Ischemic Stroke - Frontiers

Antigen-Dependent T Cell Response to Neural Peptides After Human Ischemic Stroke Frontiers

VHIR receives the Narcís Monturiol Plaque for scientific and technological merit from the Government - Vall d'Hebron Barcelona Hospital Campus

VHIR receives the Narcís Monturiol Plaque for scientific and technological merit from the Government Vall d'Hebron Barcelona Hospital Campus

The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models - Masanas - 2021 - Clinical and Translational Medicine - Wiley Online Library

The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models - Masanas - 2021 - Clinical and Translational Medicine Wiley Online Library

A Kenyan researcher is hosted at VHIR through a fellowship - Vall d'Hebron Barcelona Hospital Campus

A Kenyan researcher is hosted at VHIR through a fellowship Vall d'Hebron Barcelona Hospital Campus

A research of the VHIR's clinical pharmacology group funded by Mutual Médica - Vall d'Hebron Barcelona Hospital Campus

A research of the VHIR's clinical pharmacology group funded by Mutual Médica Vall d'Hebron Barcelona Hospital Campus

D-Sight, a Vall d’Hebron spin-off, raises 1 million euros to - Vall d'Hebron Barcelona Hospital Campus

D-Sight, a Vall d’Hebron spin-off, raises 1 million euros to Vall d'Hebron Barcelona Hospital Campus

Preliminary analysis of the study of HIPRA's vaccine against - Vall d'Hebron Barcelona Hospital Campus

Preliminary analysis of the study of HIPRA's vaccine against Vall d'Hebron Barcelona Hospital Campus

Researchers from IDIBAPS and Hospital Clínic, awarded in the VHIR Health Innovation Contest - Hospital Clínic Barcelona

Researchers from IDIBAPS and Hospital Clínic, awarded in the VHIR Health Innovation Contest Hospital Clínic Barcelona

Vall d'Hebron has participated in a clinical study that has - Vall d'Hebron Barcelona Hospital Campus

Vall d'Hebron has participated in a clinical study that has Vall d'Hebron Barcelona Hospital Campus

Researchers identify the bacteria responsible for the discomfort caused by abdominal gases - Gut Microbiota for Health

Researchers identify the bacteria responsible for the discomfort caused by abdominal gases Gut Microbiota for Health

A New Risk Variant for Multiple Sclerosis is associated with the expansion of CXCR5+ circulating regulatory T cells - uab.cat

A New Risk Variant for Multiple Sclerosis is associated with the expansion of CXCR5+ circulating regulatory T cells uab.cat

Dr. Eva Baldrich presents VHIR's research in nanomedicine at a conference in Thailand - Vall d'Hebron Barcelona Hospital Campus

Dr. Eva Baldrich presents VHIR's research in nanomedicine at a conference in Thailand Vall d'Hebron Barcelona Hospital Campus

A Vall d'Hebron study highlights the potential of probiotics - Vall d'Hebron Barcelona Hospital Campus

A Vall d'Hebron study highlights the potential of probiotics Vall d'Hebron Barcelona Hospital Campus

Strong presence of VHIR's Hepato-Bilio-Pancreatic Surgery - Vall d'Hebron Barcelona Hospital Campus

Strong presence of VHIR's Hepato-Bilio-Pancreatic Surgery Vall d'Hebron Barcelona Hospital Campus

Genetic basis of ADHD and autism spectrum disorder impacts on children's school performance - Vall d'Hebron Barcelona Hospital Campus

Genetic basis of ADHD and autism spectrum disorder impacts on children's school performance Vall d'Hebron Barcelona Hospital Campus

Vall d'Hebron obtains more than €1 million in profit from the use of a patent licence - Vall d'Hebron Barcelona Hospital Campus

Vall d'Hebron obtains more than €1 million in profit from the use of a patent licence Vall d'Hebron Barcelona Hospital Campus

A new European project awarded to the CIBBIM-Nanomedicine of - Vall d'Hebron Barcelona Hospital Campus

A new European project awarded to the CIBBIM-Nanomedicine of Vall d'Hebron Barcelona Hospital Campus

Early initiation of specific treatment for migraine improves the course of the disease - Vall d'Hebron Barcelona Hospital Campus

Early initiation of specific treatment for migraine improves the course of the disease Vall d'Hebron Barcelona Hospital Campus

Seminari VHIR - Dr. Yenan Bryceson "Hemophagocytic - Vall d'Hebron Barcelona Hospital Campus

Seminari VHIR - Dr. Yenan Bryceson "Hemophagocytic Vall d'Hebron Barcelona Hospital Campus

Targeted resequencing reveals rare variants enrichment in Multiple Sclerosis susceptibility genes - uab.cat

Targeted resequencing reveals rare variants enrichment in Multiple Sclerosis susceptibility genes uab.cat

BAAS & ESPINET UBACH won the contest refurbishment of the Hospital Campus and the new Research Institute (VHIR) - Metalocus

BAAS & ESPINET UBACH won the contest refurbishment of the Hospital Campus and the new Research Institute (VHIR) Metalocus

MicroRNAs are involved in the cutaneous Lupus disease - uab.cat

MicroRNAs are involved in the cutaneous Lupus disease uab.cat

Stroke: searching for biomarkers to predict evolution - uab.cat

Stroke: searching for biomarkers to predict evolution uab.cat

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant